The main objective of this study was to determine the prevalence of the Qnr 2 determinants in clinical and environmental Aeromonas spp. A total of 52 Aeromonas 3 spp. strains identified by biochemical methods (5), 25 isolated from natural waters (1) 4 and 27 isolated from clinical samples in hospitals from Valencia (Spain), were tested for 5 quinolones resistance by the disk diffusion method (4) (nalidixic acid 30 µg, oxolinic 6 acid 2 µg, flumequine 30 µg, ciprofloxacin 5 µg and levofloxacin 5 µg). Among the 7 studied isolates, 27 showed resistance to nalidixic acid and susceptibility to 8 ciprofloxacin; 24 isolates were susceptible to both, nalidixic acid and ciprofloxacin; 9 only one, the A. veronii A272 clinical isolate was resistant to both nalidixic acid and 10 ciprofloxacin. The isolates resistant to nalidixic acid were also resistant to oxolinic acid 11 and flumequine. Moreover, A. veronii A272 was the only one resistance to levofloxacin. 12
the gyrA and parC genes was performed with primers previously described (7). A. 27 veronii CECT 4260 and CECT 4258 strains, susceptible to quinolones, were included. 28
The nucleotide and deduced protein sequences were analyzed with software available 29 over the internet at the National Center for Biotechnology Information website 30 (http://www.ncbi.nlm.nih.gov). Comparison of the deduced amino acid sequences of 31
GyrA and ParC with those of susceptible A. veronii CECT 4258 and CECT 4260 strains 32
showed that A. veronii A272 carried mutations in the QRDRs of both gyrA and parC 33 genes (Table) . As previously reported, the same mutations were found in a strain that 34
showed a MIC to ciprofloxacin of 0.5 mg/L (7). Therefore the level of resistance to 35 these antibacterial agents could be explained by these two mutations in the gyrA and 36 parC genes plus the additive effect of the presence of the QnrS2 determinant (Table) . In addition, we did notobserve increased resistance to β-lactam antibiotics, aminoglycosides, chloramphenicol 48 and tetracycline in the transformed E. coli strain (data not shown). 49 GyrA ParC
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